Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
1483
-
Total 13F shares, excl. options
-
209M
-
Shares change
-
-2.39M
-
Total reported value, excl. options
-
$96.3B
-
Value change
-
-$1.14B
-
Put/Call ratio
-
1.05
-
Number of buys
-
650
-
Number of sells
-
-679
-
Price
-
$459.81
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q1 2023
1,678 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q1 2023.
Elevance Health, Inc. - Common Stock (ELV) has 1,483 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 209M shares
of 226M outstanding shares and own 92.61% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (21.5M shares), BlackRock Inc. (20.8M shares), PRICE T ROWE ASSOCIATES INC /MD/ (13.3M shares), STATE STREET CORP (11M shares), WELLINGTON MANAGEMENT GROUP LLP (8.46M shares), Capital International Investors (4.85M shares), FMR LLC (4.81M shares), GEODE CAPITAL MANAGEMENT, LLC (4.28M shares), Sanders Capital, LLC (4.02M shares), and AMERIPRISE FINANCIAL INC (3.62M shares).
This table shows the top 1483 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.